Literature DB >> 25460264

Behavioral activation in acute inpatient psychiatry: a multiple baseline evaluation.

Fredrik Folke, Timo Hursti, Stefan Tungström, Per Söderberg, Jonathan W Kanter, Klara Kuutmann, Hanna Olofsson, Lisa Ekselius.   

Abstract

BACKGROUND AND OBJECTIVES: The present study employed a multiple baseline study design with repeated measures to explore clinical outcomes, therapy mechanisms, and feasibility of Behavioral Activation for persons admitted to inpatient psychiatry.
METHODS: Six adult inpatients with depressive symptoms and different psychiatric disorders were randomized to different lengths of baseline standard inpatient treatment. Subsequently a 5-day, 10-session Behavioral Activation protocol was added. Daily self-report outcome and process measures were administered and supplemented with hourly self-reports and clinician assessments before and after each study phase.
RESULTS: After a relatively stable baseline, at least four participants showed marked gradual improvements both in terms of outcome as well as activation and avoidance as Behavioral Activation was initiated. The temporal relation between process and outcome differed somewhat across metrics. In most instances however, change in activation and avoidance either coincided or preceded decreased depression. LIMITATIONS: We did not include some relatively common disorders, did not control for the effects of increased attention, did not investigate treatment integrity, and did not conduct follow-up after discharge. Raters were not blind and measures were mainly focused on depressive symptoms. All received concurrent medical treatment.
CONCLUSIONS: This preliminary study further supports the promise of Behavioral Activation as an inpatient treatment for persons with a variety of psychiatric disorders. Results also lends preliminary support for the purported mechanisms of Behavioral Activation.

Entities:  

Mesh:

Year:  2015        PMID: 25460264     DOI: 10.1016/j.jbtep.2014.10.006

Source DB:  PubMed          Journal:  J Behav Ther Exp Psychiatry        ISSN: 0005-7916


  6 in total

1.  Advancing Care Within an Adult Mental Health Day Hospital: Program Re-Design and Evaluation.

Authors:  Marlene Taube-Schiff; Adrienne Mehak; Sandy Marangos; Anastasia Kalim; Thomas Ungar
Journal:  J Behav Health Serv Res       Date:  2019-01       Impact factor: 1.505

2.  Exploring how to improve access to psychological therapies on acute mental health wards from the perspectives of patients, families and mental health staff: qualitative study.

Authors:  Katherine Berry; Jessica Raphael; Gillian Haddock; Sandra Bucci; Owen Price; Karina Lovell; Richard J Drake; Jade Clayton; Georgia Penn; Dawn Edge
Journal:  BJPsych Open       Date:  2022-06-14

3.  Effectiveness of a web-based behavioural activation intervention for individuals with depression based on the Health Action Process Approach: protocol for a randomised controlled trial with a 6-month follow-up.

Authors:  Lena Violetta Krämer; Claudia Mueller-Weinitschke; Tina Zeiss; Harald Baumeister; David Daniel Ebert; Jürgen Bengel
Journal:  BMJ Open       Date:  2022-01-24       Impact factor: 2.692

4.  Staff experiences related to implementation of a recovery-oriented nursing programme in psychiatric inpatient care.

Authors:  Johanna Salberg; Lisa Ekselius; Timo Hursti; Caisa Öster
Journal:  Int J Ment Health Nurs       Date:  2022-03-21       Impact factor: 5.100

5.  Functioning of the EROS-R Scale in a Clinical Sample of Psychiatric Patients: New Psychometric Evidence from the Classical Test Theory and the Item Response Theory.

Authors:  Lindsey W Vilca; Evelyn L Chambi-Mamani; Emely D Quispe-Kana; Mónica Hernández-López; Tomás Caycho-Rodríguez
Journal:  Int J Environ Res Public Health       Date:  2022-08-15       Impact factor: 4.614

6.  Activation therapy for the treatment of inpatients with depression - protocol for a randomised control trial compared to treatment as usual.

Authors:  Ian R E Averill; Ben Beaglehole; Katie M Douglas; Jennifer Jordan; Marie T Crowe; Maree Inder; Cameron J Lacey; Christopher M Frampton; Christopher R Bowie; Richard J Porter
Journal:  BMC Psychiatry       Date:  2019-02-01       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.